Wang et al. [47] found that overexpression of MIR-211 can act on the TDP1 target in breast cancer cells, thereby inhibiting its expression, further inhibiting DDR, and reversing the resistance of breast cancer to neoadjuvant chemotherapy drugs. The gene discussed is TDP1; the disease is breast carcinoma.